Dr. Russell Jaffe discusses the hydroxocobalamin form of vitamin B12 and whether it might be problematic in patients with nitric oxide deficiency.
Effective December 18, 2024, ELISA/ACT Biotechnologies will be temporarily closing for operational research and improvement
